Tics & Tourette Syndrome

What You'll Learn

Tics are sudden, rapid, recurrent, non-rhythmic movements or vocalizations preceded by a premonitory urge and are temporarily suppressible
Tourette syndrome: multiple motor tics + ≥1 vocal tic, onset <18 years, duration >1 year (DSM-5); male predominance 3–4:1. The most common initial tic is eye blinking (frequently tested board fact); motor tics typically precede vocal tics by 1–2 years.
Tics wax and wane in severity, type, and location over time — this fluctuation is characteristic
Comorbidities often more disabling than tics: ADHD (50–60%), OCD (40–60%), anxiety, depression
CBIT is first-line behavioral treatment; alpha-2 agonists (guanfacine, clonidine) first-line pharmacologic
Antipsychotics (fluphenazine, aripiprazole, pimozide) for severe/refractory tics — monitor QTc with pimozide

HighYield Pearls

Tourette DSM-5: ≥2 motor tics + ≥1 vocal/phonic tic (need not be concurrent), duration >1 year, onset before age 18
Chronic (persistent) tic disorder: motor OR vocal tics (not both) >1 year; provisional tic disorder: <1 year duration
Premonitory urge preceding the tic + temporary voluntary suppressibility with rebound = hallmark distinguishing tics from other hyperkinetic movements
Tics wax and wane, worsen with stress/excitement/fatigue, improve with focused activity and sleep
Coprolalia is rare (~10–15%) and NOT required for diagnosis — common board trap; eye blinking is the most common initial tic
Comorbidities dominate the disease: ADHD ~50%, OCD ~50%, anxiety, depression, rage attacks — often more disabling than tics themselves; treat the most impairing condition first
PANDAS = abrupt prepubertal onset of OCD/tics after Group A strep (check ASO, anti-DNase B); PANS = broader non-strep triggers
Functional tic-like behaviors (rapid-onset adolescent females, COVID-era TikTok exposure surge): no premonitory urge, fixed/stereotyped, distractible, frequent complex coprolalia — do NOT respond to dopamine blockers
First-line treatment: CBIT (Comprehensive Behavioral Intervention for Tics) including HRT (Habit Reversal Training) — Level A evidence
First-line pharmacotherapy: α-2 agonists (guanfacine > clonidine) — especially when comorbid ADHD present; stimulants are NOT contraindicated in Tourette + ADHD despite the myth
Refractory tics: antipsychotics (aripiprazole, risperidone, pimozide—ECG for QTc, haloperidol), VMAT2 inhibitors (tetrabenazine), botulinum toxin for focal tics, DBS (CM thalamus or GPi) for severe adult-refractory cases in expert centers — not FDA-approved for Tourette in the US (off-label/investigational)

🔍 Quick ReferenceClinical · Comorbidity / mimic · Treatment

Clinical phenotype

Premonitory urge (“itch”/“pressure”) relieved by movement → tic
Temporary voluntary suppressibility with rebound buildup → tic (vs chorea, myoclonus)
Waxing-waning + worse with stress, better with focused activity → primary tic disorder
≥2 motor tics + ≥1 vocal tic, >1 year, onset <18 → Tourette syndrome (DSM-5)
Eye blinking as first tic in a young boy → Tourette (3–4:1 male predominance)
Coprolalia, echolalia, palilalia, echopraxia, copropraxia → complex tics

Comorbidities / mimics

Abrupt prepubertal OCD/tics after sore throat + elevated ASO/anti-DNase B → PANDAS
Same phenotype triggered by mycoplasma or viral infection (non-strep) → PANS
Adolescent female, rapid-onset complex tics, no premonitory urge, TikTok exposure → functional tic-like behavior
Fixed stereotyped pattern, distractible, female predominance, poor med response → functional tics
“Just right” symmetry/ordering compulsions → Tourette-associated OCD (vs contamination-type primary OCD)
Tics + chorea + lip/tongue self-mutilation + acanthocytes → neuroacanthocytosis
Juvenile-onset tics evolving with chorea + family history → Huntington disease
Adult-onset tics, no premonitory urge, no waxing/waning → secondary tics (stroke, TBI, encephalitis, drug-induced)

Treatment / pharmacology pearls

CBIT / HRT (awareness + competing response training) → first-line behavioral therapy (Level A)
Guanfacine, clonidine (α-2 agonists) → first-line pharmacotherapy, especially with comorbid ADHD
Aripiprazole, risperidone, haloperidol, pimozide → antipsychotics for refractory tics (pimozide → QTc monitoring)
Tetrabenazine, deutetrabenazine, valbenazine (VMAT2 inhibitors) → off-label severe tics (deutetra/valbenazine failed pediatric RCTs)
Topiramate → adjunct with RCT support, weight-neutral option
Botulinum toxin → focal motor/vocal tics — may reduce premonitory urge too
DBS CM-Pf thalamus or GPi → severe treatment-refractory adult Tourette in expert multidisciplinary centers; in the US it is not an FDA-approved Tourette indication and is generally off-label/investigational
SSRI + CBT for OCD; methylphenidate/stimulants for ADHD → treat comorbidities (stimulants generally tic-neutral — TACT trial)

Tic Classification

Definition & Key Features

Premonitory urge: uncomfortable sensory phenomenon preceding the tic (“itch” or “pressure”) — present in >90% of patients ≥10 years
Suppressibility: voluntarily suppressed for brief periods, but suppression builds urge (“rebound”)
Suggestibility: tics may increase when discussed or observed
Waxing and waning: severity fluctuates over weeks to months; types and locations change over time
Exacerbating: stress, fatigue, anxiety, excitement — Improving: focused concentration, sleep

Tic Types

Category	Description	Examples
Simple Motor	Brief, sudden, meaningless	Eye blinking (most common initial tic), facial grimacing, head jerking, shoulder shrugging
Complex Motor	Coordinated, purposeful-appearing	Touching objects, jumping, squatting, copropraxia (obscene gestures), echopraxia (imitating movements)
Simple Vocal	Meaningless sounds	Sniffing, throat clearing, grunting, barking, coughing
Complex Vocal	Linguistically meaningful	Coprolalia (obscene words — ~10–15% of Tourette), echolalia (repeating others’ words), palilalia (repeating own words)

DSM-5 Tic Disorder Spectrum

Provisional tic disorder: Motor and/or vocal tics, duration <1 year, onset <18 years
Persistent (chronic) tic disorder: Motor OR vocal tics (not both), duration >1 year, onset <18 years
Tourette syndrome: Multiple motor tics + ≥1 vocal tic (not necessarily concurrent), duration >1 year, onset <18 years

💎 Board Pearl

Premonitory urge + suppressibility + waxing/waning = tics. The premonitory urge is the most distinguishing feature from other hyperkinetic movements.
Coprolalia occurs in ~10–15% of Tourette patients — NOT required for diagnosis.
Eye blinking is the most common initial tic. Motor tics typically precede vocal tics by 1–2 years.

Tourette Syndrome

Epidemiology & Genetics

Prevalence: ~1% of school-age children; male:female = 3–4:1
Age of onset: typically 4–6 years; peak severity: 10–12 years
Natural history: ~75–90% experience substantial reduction in tic severity by adulthood; ~1/3 achieve near/complete remission, ~1/3 have mild residual tics, ~1/3 have persistent moderate-to-severe tics
Genetics: Polygenic; MZ twin concordance 50–77%; SLITRK1 and HDC implicated in rare families

Pathophysiology

Cortico-striato-thalamo-cortical (CSTC) circuit dysfunction — disinhibition of motor and limbic circuits
Reduced caudate volume; dopamine hypothesis: hypersensitive striatal dopaminergic signaling — supported by response to D2 blockers

Diagnosis

Clinical diagnosis — no confirmatory lab or imaging required
DSM-5: Multiple motor + ≥1 vocal tic (need not be concurrent); >1 year duration; onset <18; not due to substance/medical condition
YGTSS (Yale Global Tic Severity Scale): Standardized rating of tic number, frequency, intensity, complexity, interference

Clinical Pearl

Motor and vocal tics do NOT need to occur simultaneously — both just need to have been present at some point during the illness.
Tic severity does not predict comorbidity severity — mild tics may coexist with severely disabling OCD or ADHD.

🔒

Continue reading — sign in

The full note has more clinical pearls, tables, and board-focused tips. Free account, no fee.